Enfermedad coronaria estable, identificación del riesgo

1. Calvert PA, Steg PG. Towards evidence-based percutaneous coronary intervention: the Rene Laennec lecture in clinical cardiology. Eur Heart J. 2012; 33(15):1878-1885.
2. Fihn SD, Gardin JM, Abrams J, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J AmColl Cardiol. 2012; 60(24):e44-e164.
3. Steg PG. Heart rate management in coronary artery disease: the CLARIFY registry. Eur Heart J Suppl. 2009;11(suppl D):D13-D18. doi:10.1093 /eurheartj/sup017.
4. Ferrari R, Abergel H, Ford I, et al. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol. 2013; 167(6):2938-2943.
5. Steg PG, Ferrari R, Ford I, et al; CLARIFY Investigators. Heart rate and use of β-blockers in stable outpatients with coronary artery disease. PLoS One. 2012; 7(5):e36284.
6. Steg PG, Greenlaw N, Tardif JC, et al; CLARIFY Registry Investigators.Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J. 2012; 33 (22):2831-2840.
7. Campeau L. Grading of angina pectoris [letter]. Circulation. 1976; 54(3):522-523.
8. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, MA: Little Brown & Co; 1994.
9. Wilson PW, D'Agostino R Sr, Bhatt DL, et al; REACH Registry. An international model to predict recurrent cardiovascular disease. Am J Med. 2012; 125(7):695-703.e1. doi:10.1016/j.amjmed.2012.01.014.
10. Gehi AK, Rumsfeld JS, Liu H, Schiller NB, Whooley MA. Relation of self-reported angina pectoris to inducible myocardial ischemia in patients with known coronary artery disease: the Heart and Soul Study. Am J Cardiol. 2003; 92(6): 705-707.
11. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation. 2000; 101 (12):1465-1478.
12. Machecourt J, Longere P, Fagret D, et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect: study in 1,926 patients with follow-up at 33 months. J AmColl Cardiol. 1994; 23 (5):1096-1106.
13. Vanzetto G, Ormezzano O, Fagret D, Comet M, Denis B, Machecourt J. Long-term additive prognostic value of thallium-201myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation. 1999; 100(14):1521-1527.
14. LadenheimML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986; 7 (3):464-471.
15. Hachamovitch R, Rozanski A, Hayes SW, et al. Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol. 2006; 13(6):768-778.
16. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally non significant stenosis: 5-year follow-up of the DEFER Study. J AmColl Cardiol. 2007; 49(21):2105-2111.
17. De Bruyne B, Pijls NH, Kalesan B, et al; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease [published correction appears in N Engl J Med. 2012; 367(18):1768]. N Engl J Med. 2012; 367
(11):991-1001.
18. Fassa AA,Wijns W, Kolh P, Steg PG. Benefit of revascularization for stable ischaemic heart disease: the jury is still out. Eur Heart J. 2013; 34(21):1534-1538.
19. Gehi AK, Ali S, Na B, Schiller NB, Whooley MA. Inducible ischemia and the risk of recurrent cardiovascular events in outpatients with stable coronary heart disease: the Heart and Soul Study. Arch Intern Med. 2008; 168(13):1423-1428.
20. Cohn PF, Harris P, Barry WH, Rosati RA, Rosenbaum P, Waternaux C. Prognostic importance of anginal symptoms in angiographically defined coronary artery disease. Am J Cardiol. 1981; 47(2): 233-237.
21. Mozaffarian D, Bryson CL, Spertus JA, McDonell MB, Fihn SD. Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease. Am Heart J. 2003; 146(6): 1015-1022.
22. Berecki-Gisolf J, Humphreyes-Reid L,Wilson A, Dobson A. Angina symptoms are associated with mortality in older women with ischemic heart disease. Circulation. 2009; 120(23):2330-2336.
23. Hemingway H, McCallum A, Shipley M, Manderbacka K, Martikainen P, Keskimaki I. Incidence and prognostic implications of stable angina pectoris among women and men. JAMA. 2006; 295(12):1404-1411.
24. Dagenais GR, Lu J, Faxon DP, et al; BARI 2D Study Group. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial. J AmColl Cardiol. 2013; 61(7):702-711.
25. Stone PH. Ischemia dictates outcome, not symptoms. J AmColl Cardiol. 2013; 61(7):712-713.
26. Mulcahy D, Husain S, Zalos G, et al. Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease. JAMA. 1997; 277(4):318-324.
27. Mulcahy DA. The return of silent ischaemia? Not really. Heart. 2005; 91(10):1249-1250.
28. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995; 92(3):657-671.
29. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J AmColl Cardiol. 1995; 25 (2):333-341.
30. Zellweger MJ, Hachamovitch R, Kang X, et al. Threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease. J Nucl Cardiol. 2009; 16(2): 193-200.